Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Mar;32(3):201-15.
doi: 10.1007/s40266-015-0246-0.

Chronic pruritus in the elderly: pathophysiology, diagnosis and management

Affiliations
Review

Chronic pruritus in the elderly: pathophysiology, diagnosis and management

Rodrigo Valdes-Rodriguez et al. Drugs Aging. 2015 Mar.

Abstract

Chronic itch in the elderly is a common problem, with a significant impact on quality of life and sleep in elderly patients. Chronic itch may be attributable to several causes, including dry skin, immunosenescence and neural degeneration. Itch may also be caused by skin diseases, such as seborrhoeic dermatitis and stasis dermatitis; systemic conditions, such as end-stage renal disease and diabetes; and psychogenic conditions, such as depression and anxiety. The use of polypharmacy may also cause itch, with or without a rash. Specifically, thiazides and calcium channel blockers have been known to cause itch in elderly patients. Management should be tailored according to the underlying dermatological or systemic aetiology of itch. Topical treatment is the mainstay of therapy, providing special emphasis on skin hydration and barrier repair. In addition, topical and oral medications that target the nervous system and reduce neuronal hypersensitization, such as gabapentin and selective antidepressants, have a role in treating patients with severe chronic itch. Furthermore, management must account for changes in metabolism and pharmacokinetics of drugs in the aging population in order to prevent the occurrence of adverse effects.

PubMed Disclaimer

References

    1. Acta Derm Venereol. 2015 Mar;95(3):261-5 - PubMed
    1. Int J Cosmet Sci. 2004 Feb;26(1):1-7 - PubMed
    1. Nepal Med Coll J. 2012 Sep;14(3):193-5 - PubMed
    1. J Eur Acad Dermatol Venereol. 1999 May;12(3):215-21 - PubMed
    1. N Engl J Med. 2013 Apr 25;368(17):1625-34 - PubMed

Publication types